Aditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing Requirements

Rhea-AI Summary

Aditxt (NASDAQ: ADTX), a social innovation platform focused on health innovations, has announced its Weekly Update event scheduled for today at 11:30 a.m. ET. The virtual meeting will address several key developments, including the company's recent achievement of regaining compliance with Nasdaq's minimum bid price requirement, ensuring continued listing on the Nasdaq Capital Market.

The event will also provide updates on the company's operating subsidiaries and discuss ongoing strategic transactions. The meeting will be held virtually via Zoom, with registration required for attendance.

Positive

• Regained compliance with Nasdaq minimum bid price requirement
• Maintained listing status on Nasdaq Capital Market

Negative

• None.

The event will begin today at 11:30 a.m. ET

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, announced that today’s Aditxt Weekly Update will provide key updates on recent events, including:

• Aditxt’s recent notice from Nasdaq that it had regained compliance with Nasdaq’s minimum bid price requirement and is therefore in compliance with the Nasdaq Capital Market’s listing requirements
• Updates on the Company’s operating subsidiaries
• Progress on strategic transactions currently underway

Event Details:
Title: Aditxt Weekly Update
Date: Friday, April 11, 2025
Time: 11:30 a.m. ET
Location: Virtual (Zoom)
Registration: Click here to register

About Aditxt

Aditxt, Inc.^® is a social innovation platform accelerating promising health innovations. Aditxt’s ecosystem of research institutions, industry partners, and shareholders collaboratively drives its mission to "Make Promising Innovations Possible Together." The innovation platform is the cornerstone of Aditxt’s strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Aditxt operates a unique model that democratizes innovation, ensures every stakeholder’s voice is heard and valued, and empowers collective progress.

Aditxt currently operates two programs focused on immune health and precision health. The Company plans to introduce two additional programs dedicated to public health and women’s health. For these, Aditxt has entered into an Arrangement Agreement with Appili Therapeutics, Inc. ("Appili") (TSX: APLI; OTCPink: APLIF), which focuses on infectious diseases, and a Merger Agreement with Evofem Biosciences, Inc. ("Evofem") (OTCQB: EVFM). Each program will be designed to function autonomously while collectively advancing Aditxt’s mission of discovering, developing and deploying innovative health solutions to tackle some of the most urgent health challenges. The closing of each of the transactions with Appili and Evofem is subject to several conditions, including but not limited to approval of the transactions by the respective target shareholders and Aditxt raising sufficient capital to fund its obligations at closing. These obligations include cash payments of approximately $17 million for Appili and $17 million for Evofem, which includes approximately $15.2 million required to satisfy Evofem's senior secured noteholder; should Aditxt fail to secure these funds, Evofem's senior secured noteholder is expected to seek to prevent the closing of the merger with Evofem. On Dec. 23, 2024, Evofem announced the cancellation of its special stockholders meeting and the withdrawal of the merger proposal with Aditxt from consideration by the stockholders. No assurance can be provided that all of the conditions to closing will be obtained or satisfied or that either of the transactions will ultimately close.

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements" within the meaning of federal securities laws. Forward-looking statements include statements regarding the Company’s intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ongoing and planned product and business development; the Company’s ability to finance and execute its strategic M&A initiatives; the Company’s ability to obtain the necessary funding and partner to commence clinical trials; the Company’s intellectual property position; the Company’s ability to develop commercial functions; expectations regarding product launch and revenue; the Company’s results of operations, cash needs, spending, financial condition, liquidity, prospects, growth, and strategies; the Company’s ability to raise additional capital; expected usage of the Company’s ELOC and ATM facilities; the industry in which the Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, as well as market and other conditions and those risks more fully discussed in the section titled "Risk Factors" in Aditxt’s most recent Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in the Company’s other filings with the Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250411071837/en/

Aditxt, Inc.

Corporate Communications

Jeff Ramson, PCG Advisory, Inc.

T: 646-863-6893

Source: Aditxt, Inc.

FAQ

What is the significance of ADTX regaining Nasdaq compliance?

Regaining compliance with Nasdaq's minimum bid price requirement ensures ADTX can maintain its listing on the Nasdaq Capital Market, providing continued access to public markets and investor visibility.

When is Aditxt (ADTX) holding its Weekly Update event?

Aditxt's Weekly Update is scheduled for Friday, April 11, 2025, at 11:30 a.m. ET via Zoom.

What topics will be covered in ADTX's Weekly Update?

The update will cover Nasdaq compliance status, updates on operating subsidiaries, and progress on ongoing strategic transactions.

How can investors attend ADTX's Weekly Update event?

Investors can attend the virtual event via Zoom by registering through the provided registration link.